We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Global License Agreement for the Commercialization of Vitreolysis Therapy

Product News   Apr 01, 2020

 
Global License Agreement for the Commercialization of Vitreolysis Therapy

Credit: Daniil Kuzelev via Unsplash

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Avacta Announces Distribution Agreement With ABCAM plc

Product News

Avacta Group plc has announced that it has entered into a global distribution agreement with ABCAM plc to sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer® reagents.

READ MORE

Metrion Biosciences Closes £2.7m New Equity Financing

Product News

Metrion Biosciences Limited has announced that it has secured £2.7m in new equity financing, including £2.25m from lead investor Gresham House Ventures. The funding will be used to expand Metrion’s laboratories in Cambridge, UK, invest in specialist equipment, develop its cell line library, and add GLP cardiac safety services.

READ MORE

BioStrata Further Enhances its Rapidly Growing Marketing and PR Teams

Product News

BioStrata has appointed four new team members to meet growing demand and the changing requirements of clients within life sciences.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE